Intervertebral disc versus vertebral body as the percutaneous sample site for pyogenic spondylodiscitis: Which yields a higher microbiological diagnosis? A prospective study
In brief
Disc biopsies yielded positive cultures in 52%, versus 32% for vertebral biopsies
In a prospective study of 68 patients with suspected spinal infection, disc samples grew bacteria in 35 patients, compared with 22 for vertebral body samples. The paired results support targeting the disc when solid-tissue biopsy is needed, but the study was conducted at one center and does not establish whether this approach improves treatment or patient outcomes.
- Journal
- The spine journal : official journal of the North American Spine Society (Q1)
- Published
- 14 November 2026
- Study design
- Prospective / inception cohort
- Evidence level
- Level 2, Moderate (CEBM 2b)
- Authors
- Kai Tang, Yongchao Li, Yongxiong He, Jun Fan, Guangxuan Yan, Yuan Li, et al.
- PMID
- 43033832
- DOI
- 10.1016/j.spinee.2026.11.004
Why clinicians should know about it
- Picked for Microbiology (medical) (paper of the day, 16 November 2026): Prospectively compares biopsy sites for microbiological diagnostic yield
Abstract
BACKGROUND CONTEXT: Pyogenic spondylodiscitis requires microbiological confirmation, yet percutaneous sample collection yield remains modest. The optimal sampling site in patients without drainable abscess is controversial. Retrospective studies suggest the disc may outperform the vertebral body, but evidence is limited by design biases, leaving the question unresolved. PURPOSE: To determine whether the intervertebral disc or the vertebral body provides a better percutaneous biopsy site for microbiological diagnosis in patients with pyogenic spondylodiscitis. STUDY DESIGN: Prospective cohort study conducted at a single spine center. PATIENT SAMPLE: A total of 68 patients with high clinical suspicion of pyogenic spondylodiscitis who underwent C-arm guided percutaneous biopsy between January 2024 and April 2025. OUTCOME MEASURES: Positive rate of bacterial culture (including aerobic and anaerobic) from biopsy specimens; factors associated with positive culture using generalized estimating equations (GEE). METHODS: All enrolled patients underwent simultaneous percutaneous sample collections of both the vertebral body and the intervertebral disc under C-arm guidance. Specimens were sent for bacterial culture, anaerobic culture, metagenomic next-generation sequencing (mNGS), and histopathological examination. The McNemar test was used to compare paired culture positivity rates between the two sites. Multivariable analysis was performed using GEE to identify factors associated with positive cultures. RESULTS: Of 279 screened patients with suspected spinal infections, 68 were included (39 males, 29 females; median age 64.0 years). The intervertebral disc yielded a significantly higher microbial identification rate than the vertebral body (35/68 [51.5%] vs. 22/68 [32.4%]; P=0.002). On multivariable analysis, factors significantly associated with positive cultures included male sex, elevated preoperative dynamic erythrocyte sedimentation rate (ESR), increased procalcitonin (PCT), elevated interleukin-6 (IL-6), histopathological evidence of acute inflammation, and biopsy site (all P<0.05). Notably, the intervertebral disc site remained independently associated with higher culture positivity. CONCLUSIONS: In patients with pyogenic spondylodiscitis requiring solid-tissue sampling, percutaneous sampling of the intervertebral disc yields a significantly higher bacterial culture positivity rate than sampling of the vertebral body. Male sex, elevated ESR, PCT, IL-6, and acute inflammation on histopathology are also associated with positive cultures. These findings support prioritizing the intervertebral disc as the preferred percutaneous sampling target-reserving direct aspiration for accessible fluid collections-to optimize microbiological diagnosis in pyogenic spondylodiscitis.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.